Privacy Act, Exempt Record System; Withdrawal
Federal Register, Volume 78 Issue 10 (Tuesday, January 15, 2013)
Federal Register Volume 78, Number 10 (Tuesday, January 15, 2013)
Rules and Regulations
Page 2892
From the Federal Register Online via the Government Printing Office www.gpo.gov
FR Doc No: 2013-00723
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 21
Docket No. FDA-2011-N-0252
Office of the Secretary
45 CFR Part 5b
Privacy Act, Exempt Record System; Withdrawal
AGENCY: Office of the Secretary, Food and Drug Administration, HHS.
ACTION: Direct final rule; withdrawal.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) are withdrawing the direct final rule that August 28, 2012. HHS/FDA published the direct final rule to exempt scientific research misconduct proceedings records from certain requirements of the Privacy Act of 1974 in order to protect records compiled in the course of misconduct inquiries and investigations, and to safeguard the identity of confidential sources. The comment period closed on November 13, 2012. HHS/FDA is withdrawing the direct final rule because the Agency received significant adverse comment.
DATES: Effective Date: The direct final rule published at 77 FR 51910, August 28, 2012, is withdrawn effective January 10, 2013.
FOR FURTHER INFORMATION CONTACT: Frederick Sadler, Division of Freedom of Information, Food and Drug Administration, 12420 Parklawn Dr., Rockville, MD 20857, 301-796-8975, Frederick.Sadler@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: HHS and FDA are withdrawing the direct final rule that published in the Federal Register of Tuesday, August 28, 2012 (77 FR 51910). HHS/FDA published the direct final rule to exempt scientific research misconduct proceedings records from certain requirements of the Privacy Act of 1974 in order to protect records compiled in the course of misconduct inquiries and investigations, and to safeguard the identity of confidential sources. The comment period closed on November 13, 2012. HHS/FDA is withdrawing the direct final rule because the Agency received significant adverse comment.
Authority: Therefore, under 5 U.S.C. 552a, the direct final rule published on Tuesday, August 28, 2012, 77 FR 51910, is withdrawn.
Dated: January 10, 2013.
Approved:
Kathleen Sebelius
Secretary, Department of Health and Human Services.
FR Doc. 2013-00723 Filed 1-10-13; 4:15 pm
BILLING CODE 4160-01-P
